Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Pliant Therapeutics Inc has a consensus price target of $40.62 based on the ratings of 14 analysts. The high is $48 issued by JP Morgan on August 10, 2023. The low is $27 issued by Piper Sandler on May 18, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Leerink Partners, and HC Wainwright & Co. on September 13, 2024, September 9, 2024, and August 12, 2024, respectively. With an average price target of $36.33 between HC Wainwright & Co., Leerink Partners, and HC Wainwright & Co., there's an implied 244.39% upside for Pliant Therapeutics Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Pliant Therapeutics (NASDAQ:PLRX) was reported by HC Wainwright & Co. on September 13, 2024. The analyst firm set a price target for $38.00 expecting PLRX to rise to within 12 months (a possible 260.19% upside). 25 analyst firms have reported ratings in the last year.
The latest analyst rating for Pliant Therapeutics (NASDAQ:PLRX) was provided by HC Wainwright & Co., and Pliant Therapeutics reiterated their buy rating.
There is no last upgrade for Pliant Therapeutics
There is no last downgrade for Pliant Therapeutics.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pliant Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pliant Therapeutics was filed on September 13, 2024 so you should expect the next rating to be made available sometime around September 13, 2025.
While ratings are subjective and will change, the latest Pliant Therapeutics (PLRX) rating was a reiterated with a price target of $38.00 to $38.00. The current price Pliant Therapeutics (PLRX) is trading at is $10.55, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.